Brijesh Kumar Yadav1,2, Nicolas Currier3, Gersham Dent3, Paul S Swerdlow4, Indryas Woldie4, Muhammad Shahid4, Sean K Sethi5, Wenting Wang3, Kiarash Ghassaban5, Willem Birkhoff6, Jacobus Burggraaf6, Jaspert de Vries6, Jaladhar Neelavalli2, William E. Hobbs7, E Mark Haacke1,2, and Ajay Verma8
1Department of Biomedical Engineering, Wayne State University, Detroit, MI, United States, 2Department of Radiology, Wayne State University, Detroit, MI, United States, 3Biogen Inc., Cambridge, MA, United States, 4Department of Hematology-Oncology, Wayne State University, Detroit, MI, United States, 5MR Innovations, Detroit, MI, United States, 6Centre for Human Drug Research, Leiden, Netherlands, 7Bioverativ, a Sanofi company, Waltham, MA, United States, 8United Neuroscience, Hauppauge, NY, United States
Synopsis
Even
though the prevalence of stroke in adults with sickle cell disease (SCD) is
higher compared to children, no accepted screening measures are available for
identifying adults with SCD at high risk for strokes. Despite cerebral blood
flow (CBF) from transcranial Doppler being an established surrogate measure of
stroke risk in children, it is not feasible in adults and MRI is uneconomical
and inefficient for screening. We examined skin blood flow using laser speckle
contrast imaging as a peripheral surrogate of CBF using MRI. Skin blood flow
was highly correlated with CBF in sickle cell patients with excellent
test-retest reliability.
Introduction
Cerebrovascular
accidents (CVA), including stroke, are one of the major causes of morbidity and
mortality in patients with sickle cell disease (SCD) resulting from
vaso-occlusion of major cerebral arteries. Experience with transcranial Doppler
(TCD) ultrasonography in children highlights the importance of cerebral blood
flow (CBF) assessment in optimal management of CVA risk1,2. While the rates
of CVA are even higher in adult SCD populations3 TCD has not proven to be as
valuable a measure in the adult SCD population and less information is
available about CBF in adults with SCD4. This is likely due to closure of ultrasound
windows in adults and a more complex pathophysiology of stroke in adults with
SCD4. CBF has been an established surrogate measure of stroke risk in
children. Despite magnetic resonance imaging (MRI) being an optimal imaging
technique to evaluate CBF, the cost, time and inconvenience of MRI scans makes
it uneconomical and inefficient for the routine screening and surveillance of
SCD patients for stroke risk. Therefore, to explore more pragmatic surrogate
biomarkers of stroke in SCD patients, in this study we investigate skin blood
flow using laser speckle contrast imaging (LSCI) as a potential surrogate
biomarker of altered CBF in adults with SCD using MRI.Materials and Methods
We
enrolled SCD patients (N=18 at imaging visit 1 with 1 subject lost to
follow-up) not receiving routine blood transfusion protocols and matched
healthy volunteer controls (N=6). All MRI scans were performed at 3.0 Tesla (Siemens Healthineers, Erlangen, Germany). We investigated CBF in adults with SCD using 2
MRI techniques: arterial spin labeling (ASL) (Figure-1) and phase contrast
(PC-MRI) (Figure-2). Additionally, we measured skin blood flow using LSCI by using
perfusion and re-perfusion criteria (Figure-3). Imaging data was acquired in 2
visits for both MRI and LSCI. The association between the CBF and skin blood
flow was investigated using the Pearson’s correlation coefficient. The
intraclass correlation coefficient (ICC) was estimated for assessing
test-retest reliability of the CBF and skin blood flow. Results
A strong correlation was found between the CBF
quantified using ASL (Figure-4) or PC-MRI (Figure-5) and the baseline blood
flow in the skin as measured using LSCI in the subjects with SCD (ASL vs. LSCI:
(r = 0.56; p=0.016); PC-MRI vs. LSCI: r = 0.67, p=0.002)). Figures 4 and 5 also
show that this association was found to be significant and consistent during
imaging visit 2 (ASL vs. LSCI: (r = 0.51; p=0.038); PC-MRI vs. LSCI: r = 0.63,
p=0.006).Discussion
Baseline blood flow in
the skin as measured using LSCI was found to be a strong predictor of the
average CBF quantified using ASL or PC-MRI in adult subjects with SCD. In
addition, this correlation was highly reproducible in test-retest process. The
change in rheological properties of sickled RBCs and altered vaso-motor
function may affect the hemodynamic properties of the CNS and peripheral system
proportionally, which is captured in the strong and reproducible correlation
between CBF and skin blood flow in SCD patients. LSCI might be an inexpensive
and clinically feasible technique to indirectly assess hemodynamic changes in
the brain. With additional independent validation, LSCI may have a favorable
cost:benefit ratio based on these data, and implementation of brain MRI and
skin LSCI as exploratory endpoints to evaluate clinical correlates of increased
blood flow in SCD clinical trials is justified.Conclusion
Good
correlation was found
between alterations in CBF and skin blood flow in adult SCD patients with
significant longitudinal stability suggesting that skin blood flow measurement
using LSCI may be a more convenient proxy than MRI for routine hemodynamic
evaluation of this population.Acknowledgements
No acknowledgement found.References
1. Adams, R., et al., Longāterm stroke risk in children
with sickle cell disease screened with transcranial Doppler. Annals of
neurology, 1997. 42(5): p. 699-704.
2. Strouse, J.J., et al., Inverse correlation between
cerebral blood flow measured by continuous arterial spin-labeling (CASL) MRI
and neurocognitive function in children with sickle cell anemia (SCA). Blood, 2006. 108(1): p. 379-381.
3. Jordan,
L.C. and M.R. DeBaun, Cerebral hemodynamic assessment and neuroimaging across
the lifespan in sickle cell disease.
Journal of Cerebral Blood Flow & Metabolism, 2017: p. 0271678X17701763.
4. Jordan, L.C., et al.,
Non-invasive imaging of oxygen extraction fraction in adults with sickle cell
anaemia. Brain, 2016. 139(3): p.
738-750.